platelet derived fibroblast, nerve, and ciliary neurotrophic growth factors
How it works Choose your LOCATION Select a clinic location across Lothian, Fife, Glasgow or Tayside
Regulatory Status and Safety Takeaway FDA Status: IGF-1 LR3 is not approved by the FDA for human therapeutic use and is highly restricted
Consult Healthcare Providers: Seek medical guidance before starting BPC-157, especially for individuals with pre-existing conditions or taking concurrent medications
Our guide on foods to avoid on tirzepatide covers dietary strategies that reduce nausea, and the tirzepatide diet plan provides meal structures optimized for patients on GLP-1 therapy
Primary Handling Editor: Ulrike Harjes, in collaboration with the Nature Medicine team